Cell Sheet based Gene Therapy Market Forecast with Size and Share Analysis 2025 to 2034

Report Id: 3143 Pages: 170 Last Updated: 16 December 2025 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

Segmentation of Cell Sheet-based Gene Therapy Market -

Cell Sheet-based Gene Therapy Market by Cell-Sheet Type-

  • Monolayer Cell-sheet Type
  • Co-culture Cell-sheet Type
  • Multilayered Cell-sheet Type
  • Others

Cell Sheet-based Gene Therapy Market

Cell Sheet-based Gene Therapy Market by Source Type -

  • Allogenic
  • Autologous
  • Stem-cell Derived

Cell Sheet-based Gene Therapy Market by Technology-

  • Cell sheet-based Engineering Techniques
    • Scaffold-Free Techniques
    • Light-induced cell sheet technology
    • Layer-by-Layer Assembly
    • Temperature-Responsive Culture Surfaces
    • Others
  • Gene Delivery Methods
    • CRISPR/Cas9
    • Viral Vector-Based (e.g., Lentivirus, Adenovirus)
    • Non-Viral Vector-Based (e.g., Liposomes, Nanoparticles)
    • Others

Cell Sheet-based Gene Therapy Market by Application-

  • Oncology
  • Cardiology
  • Genetic Disorders
  • Ophthalmology
  • Others

Cell Sheet-based Gene Therapy Market by End-user-

  • Hospitals and Clinics
  • Biotech and Pharma Companies
  • Research and Academic Institutions
  • Others

Cell Sheet-based Gene Therapy Market by Region-

North America-

  • The US
  • Canada

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Cell Sheet-based Gene Therapy Market Snapshot

Chapter 4. Global Cell Sheet-based Gene Therapy Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2025-2034
4.8. Global Cell Sheet-based Gene Therapy Market Penetration & Growth Prospect Mapping (US$ Mn), 2024-2034
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2024)
4.10. Use/impact of AI on CELL SHEET-BASED GENE THERAPY MARKET Industry Trends

Chapter 5. Cell Sheet-based Gene Therapy Market Segmentation 1: By Cell-Sheet Type, Estimates & Trend Analysis
5.1. Market Share by Cell-Sheet Type, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Cell-Sheet Type:

5.2.1. Monolayer Cell-sheet Type
5.2.2. Co-culture Cell-sheet Type
5.2.3. Multilayered Cell-sheet Type
5.2.4. Others

Chapter 6. Cell Sheet-based Gene Therapy Market Segmentation 2: By Technology, Estimates & Trend Analysis
6.1. Market Share by Technology, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Technology:

6.2.1. Cell sheet-based Engineering Techniques

6.2.1.1. Light-induced cell sheet technology
6.2.1.2. Temperature-Responsive Culture Surfaces
6.2.1.3. Scaffold-Free Techniques
6.2.1.4. Layer-by-Layer Assembly
6.2.1.5. Other Techniques

6.2.2. Gene Delivery Methods

6.2.2.1. Viral Vector-Based (e.g., Lentivirus, Adenovirus)
6.2.2.2. Non-Viral Vector-Based (e.g., Liposomes, Nanoparticles)
6.2.2.3. CRISPR/Cas9
6.2.2.4. Other Gene Delivery Methods

Chapter 7. Cell Sheet-based Gene Therapy Market Segmentation 3: By Source Type, Estimates & Trend Analysis
7.1. Market Share by Source Type, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Source Type:

7.2.1. Autologous
7.2.2. Allogenic
7.2.3. Stem-cell Derived

Chapter 8. Cell Sheet-based Gene Therapy Market Segmentation 4: By Application, Estimates & Trend Analysis
8.1. Market Share by Application, 2024 & 2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application:

8.2.1. Oncology
8.2.2. Ophthalmology
8.2.3. Genetic Disorders
8.2.4. Cardiology
8.2.5. Others

Chapter 9. Cell Sheet-based Gene Therapy Market Segmentation 5: By End-User, Estimates & Trend Analysis
9.1. Market Share by End-User, 2024 & 2034
9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following End-User:

9.2.1. Hospitals and Clinics
9.2.2. Research and Academic Institutions
9.2.3. Biotech and Pharma Companies
9.2.4. Others

Chapter 10. Cell Sheet-based Gene Therapy Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. Global Cell Sheet-based Gene Therapy Market, Regional Snapshot 2024 & 2034
10.2. North America

10.2.1. North America Cell Sheet-based Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034

10.2.1.1. US
10.2.1.2. Canada

10.2.2. North America Cell Sheet-based Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Cell-Sheet Type, 2021-2034
10.2.3. North America Cell Sheet-based Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
10.2.4. North America Cell Sheet-based Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Source Type, 2021-2034
10.2.5. North America Cell Sheet-based Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.2.6. North America Cell Sheet-based Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034

10.3. Europe

10.3.1. Europe Cell Sheet-based Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034

10.3.1.1. Germany
10.3.1.2. U.K.
10.3.1.3. France
10.3.1.4. Italy
10.3.1.5. Spain
10.3.1.6. Rest of Europe

10.3.2. Europe Cell Sheet-based Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Cell-Sheet Type, 2021-2034
10.3.3. Europe Cell Sheet-based Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
10.3.4. Europe Cell Sheet-based Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Source Type, 2021-2034
10.3.5. Europe Cell Sheet-based Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.3.6. Europe Cell Sheet-based Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034

10.4. Asia Pacific

10.4.1. Asia Pacific Cell Sheet-based Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034

10.4.1.1. India
10.4.1.2. China
10.4.1.3. Japan
10.4.1.4. Australia
10.4.1.5. South Korea
10.4.1.6. Hong Kong
10.4.1.7. Southeast Asia
10.4.1.8. Rest of Asia Pacific

10.4.2. Asia Pacific Cell Sheet-based Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Cell-Sheet Type, 2021-2034
10.4.3. Asia Pacific Cell Sheet-based Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
10.4.4. Asia Pacific Cell Sheet-based Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Source Type, 2021-2034
10.4.5. Asia Pacific Cell Sheet-based Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts By Application, 2021-2034
10.4.6. Asia Pacific Cell Sheet-based Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034

10.5. Latin America

10.5.1. Latin America Cell Sheet-based Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034

10.5.1.1. Brazil
10.5.1.2. Mexico
10.5.1.3. Rest of Latin America

10.5.2. Latin America Cell Sheet-based Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Cell-Sheet Type, 2021-2034
10.5.3. Latin America Cell Sheet-based Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
10.5.4. Latin America Cell Sheet-based Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Source Type, 2021-2034
10.5.5. Latin America Cell Sheet-based Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.5.6. Latin America Cell Sheet-based Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034

10.6. Middle East & Africa

10.6.1. Middle East & Africa Cell Sheet-based Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034

10.6.1.1. GCC Countries
10.6.1.2. Israel
10.6.1.3. South Africa
10.6.1.4. Rest of Middle East and Africa

10.6.2. Middle East & Africa Cell Sheet-based Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Cell-Sheet Type, 2021-2034
10.6.3. Middle East & Africa Cell Sheet-based Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
10.6.4. Middle East & Africa Cell Sheet-based Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Source Type, 2021-2034
10.6.5. Middle East & Africa Cell Sheet-based Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.6.6. Middle East & Africa Cell Sheet-based Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034

Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles

11.2.1. Abeona Therapeutics, Inc.

11.2.1.1. Business Overview
11.2.1.2. Key Product/Service
11.2.1.3. Financial Performance
11.2.1.4. Geographical Presence
11.2.1.5. Recent Developments with Business Strategy

11.2.2. Foundation ENEA Tech Biomedical
11.2.3. Fujifilm Cellular Dynamics, Inc. (FCDI)
11.2.4. CellSeed Inc.
11.2.5. Japan Tissue Engineering Co., Ltd
11.2.6. Emmaus Medical, Inc.

Research Design and Approach

This study employed a multi-step, mixed-method research approach that integrates:

  • Secondary research
  • Primary research
  • Data triangulation
  • Hybrid top-down and bottom-up modelling
  • Forecasting and scenario analysis

This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.

Secondary Research

Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.

Sources Consulted

Secondary data for the market study was gathered from multiple credible sources, including:

  • Government databases, regulatory bodies, and public institutions
  • International organizations (WHO, OECD, IMF, World Bank, etc.)
  • Commercial and paid databases
  • Industry associations, trade publications, and technical journals
  • Company annual reports, investor presentations, press releases, and SEC filings
  • Academic research papers, patents, and scientific literature
  • Previous market research publications and syndicated reports

These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.

Secondary Research

Primary Research

Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.

Stakeholders Interviewed

Primary interviews for this study involved:

  • Manufacturers and suppliers in the market value chain
  • Distributors, channel partners, and integrators
  • End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
  • Industry experts, technology specialists, consultants, and regulatory professionals
  • Senior executives (CEOs, CTOs, VPs, Directors) and product managers

Interview Process

Interviews were conducted via:

  • Structured and semi-structured questionnaires
  • Telephonic and video interactions
  • Email correspondences
  • Expert consultation sessions

Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.

Data Processing, Normalization, and Validation

All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.

The data validation process included:

  • Standardization of units (currency conversions, volume units, inflation adjustments)
  • Cross-verification of data points across multiple secondary sources
  • Normalization of inconsistent datasets
  • Identification and resolution of data gaps
  • Outlier detection and removal through algorithmic and manual checks
  • Plausibility and coherence checks across segments and geographies

This ensured that the dataset used for modelling was clean, robust, and reliable.

Market Size Estimation and Data Triangulation

Bottom-Up Approach

The bottom-up approach involved aggregating segment-level data, such as:

  • Company revenues
  • Product-level sales
  • Installed base/usage volumes
  • Adoption and penetration rates
  • Pricing analysis

This method was primarily used when detailed micro-level market data were available.

Bottom Up Approach

Top-Down Approach

The top-down approach used macro-level indicators:

  • Parent market benchmarks
  • Global/regional industry trends
  • Economic indicators (GDP, demographics, spending patterns)
  • Penetration and usage ratios

This approach was used for segments where granular data were limited or inconsistent.

Hybrid Triangulation Approach

To ensure accuracy, a triangulated hybrid model was used. This included:

  • Reconciling top-down and bottom-up estimates
  • Cross-checking revenues, volumes, and pricing assumptions
  • Incorporating expert insights to validate segment splits and adoption rates

This multi-angle validation yielded the final market size.

Forecasting Framework and Scenario Modelling

Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.

Forecasting Methods

  • Time-series modelling
  • S-curve and diffusion models (for emerging technologies)
  • Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
  • Price elasticity models
  • Market maturity and lifecycle-based projections

Scenario Analysis

Given inherent uncertainties, three scenarios were constructed:

  • Base-Case Scenario: Expected trajectory under current conditions
  • Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
  • Conservative Scenario: Slow adoption, regulatory delays, economic constraints

Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
4915
Security Code field cannot be blank!

Frequently Asked Questions

Cell Sheet-based Gene Therapy Market Size is valued at US$ 719.9 Mn in 2024 and is predicted to reach US$ 2,405.4 Bn by the year 2034

Cell Sheet-based Gene Therapy Market is expected to grow at a 13.1% CAGR during the forecast period for 2025 to 2034.

Abeona Therapeutics Inc., Emmaus Medical, Inc, CellSeed Inc., Fujifilm Cellular Dynamics, Inc. (FCDI) (FUJIFILM Holdings Corporation), Japan Tissue En

Cell-Sheet Type, Source Type, Technology, Application, and End-user are the key segments of the Cell Sheet-based Gene Therapy Market.

North America region is leading the Cell Sheet-based Gene Therapy Market.

Report License Selection

Determine the Appropriate License for your Report

Get Sample Report Enquiry Before Buying